Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CalciMedica (CALC)
NASDAQ:CALC
CalciMedica (CALC) Stock Price & Analysis
236 Followers
CALC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.75 - $8.38
Previous Close$4.25
Volume33.64K
Average Volume (3M)37.14K
Market Cap
$45.68M
Enterprise Value$19.97M
Total Cash (Recent Filing)$25.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.41
Next Earnings
Aug 08, 2024EPS Estimate
-$0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding10,749,065
10 Day Avg. Volume11,956
30 Day Avg. Volume37,137
Standard Deviation0.39
R-Squared0.03
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)4.73
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.15
Forecast
1Y Price Target
$14.25Price Target Upside255.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
CalciMedica News
PremiumCompany Announcements
CalciMedica’s Auxora Shows Promise in Acute Pancreatitis Trial
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CALC FAQ
What was CalciMedica’s price range in the past 12 months?
CalciMedica lowest stock price was $1.75 and its highest was $8.38 in the past 12 months.
What is CalciMedica’s market cap?
Currently, no data Available
When is CalciMedica’s upcoming earnings report date?
CalciMedica’s upcoming earnings report date is Aug 08, 2024 which is in 36 days.
How were CalciMedica’s earnings last quarter?
CalciMedica released its earnings results on May 13, 2024. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.668 by $0.678.
Is CalciMedica overvalued?
According to Wall Street analysts CalciMedica’s price is currently Undervalued.
Does CalciMedica pay dividends?
CalciMedica does not currently pay dividends.
What is CalciMedica’s EPS estimate?
CalciMedica’s EPS estimate is -$0.51.
How many shares outstanding does CalciMedica have?
CalciMedica has 10,749,065 shares outstanding.
What happened to CalciMedica’s price movement after its last earnings report?
CalciMedica reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.668. Following the earnings report the stock price went up 6.731%.
Which hedge fund is a major shareholder of CalciMedica?
Among the largest hedge funds holding CalciMedica’s share is Deerfield Management Company, LP. It holds CalciMedica’s shares valued at 4M.
---
CalciMedica Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.25 (255.36% Upside)
$14.25 (255.36% Upside)
Blogger Sentiment
Bullish
CALC Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $239.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.9%
Last 30 Days ▼ 9.0%
Last 30 Days ▼ 9.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.98%
12-Months-Change
Fundamentals
Return on Equity
-76.09%
Trailing 12-Months
Asset Growth
-21.73%
Trailing 12-Months
Company Description
CalciMedica
Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve.
---
CALC Stock 12 Month Forecast
Average Price Target
$14.25
▲(255.36% Upside)
Technical Analysis
Kura Oncology
―
Revance Therapeutics
―
Ultragenyx Pharmaceutical
―
Fate Therapeutics
―
Best Analysts Covering CALC
1 Year
1 Year Success Rate
3/7 ratings generated profit
1 Year Average Return
+12.34%
reiterated a buy rating 5 days ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +12.34% per trade.
---